Zanforlini, Bruno Micael
Ceolin, Chiara
Trevisan, Caterina
Alessi, Agnese
Seccia, Daniele Michele
Noale, Marianna
Maggi, Stefania
Guarnieri, Gabriella
Vianello, Andrea
Sergi, Giuseppe
Clinical trials referenced in this document:
Documents that mention this clinical trial
Clinical trial on the effects of oral magnesium supplementation in stable-phase COPD patients
https://doi.org/10.1007/s40520-021-01921-z
Funding for this research was provided by:
Università degli Studi di Padova
Article History
Received: 16 March 2021
Accepted: 19 June 2021
First Online: 14 July 2021
Declarations
:
: The design and conduct of the clinical trial were entirely carried out by the authors of this manuscript without any indication from the company that provided the products necessary for the experimentation. The authors have no conflicts of interest to declare.
: This study does not contain any studies with animals performed by any of the authors. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (Comitato Etico per la sperimentazione clinica di Padova-protocol number 0024160) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: Patients signed informed consent regarding publishing their data.